Mycoplasma pneumoniae -induced-stevens johnson syndrome: Rare occurrence in an adult patient

Case Reports in Medicine

Volumn 2012, Issue , 2012, Pages

  Rasul, Samad ^a   Farhat, Faria ^a   Endailalu, Yared ^a   Tabassum Khan, Fatima ^a   Poddar, Vishal ^a  

^a HOWARD UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROMYCIN; IMMUNOGLOBULIN; MEPREDNISONE; MOXIFLOXACIN;

ADULT; AFRICAN AMERICAN; ARTICLE; BLURRED VISION; CASE REPORT; COUGHING; DISEASE COURSE; EYE DISEASE; FEVER; HUMAN; MALE; MYCOPLASMA PNEUMONIA; PRIORITY JOURNAL; RASH; RHINORRHEA; SORE THROAT; STEVENS JOHNSON SYNDROME; TREATMENT RESPONSE;

EID: 84906791518     PISSN: 16879627     EISSN: 16879635     Source Type: Journal    
DOI: 10.1155/2012/430490     Document Type: Article

References (11)

1. Schalock P. C., Dinulos J. G. H., Mycoplasma pneumoniae-induced cutaneous disease. International Journal of Dermatology 2009 48 7 673 681 2-s2.0-67649216833 10.1111/j.1365-4632.2009.04154.x
2. Kunimi Y., Hirata Y., Aihara M., Statistical analysis of Stevens-Johnson syndrome caused by Mycoplasma pneumonia infection in Japan. Allergology International 2011 60 525 532
3. Wetter D. A., Camilleri M. J., Clinical, etiologic, and histopathologic features of Stevens-Johnson syndrome during an 8-year period at Mayo Clinic. Mayo Clinic Proceedings 2010 85 2 131 138 2-s2.0-75749150504 10.4065/mcp.2009.0379
4. Walicka M., Majsterek M., Rakowska A., Sowiska M., Siciska J., Góralska B., Ptasiska M., Rudnicka L., Marcinowska-Suchowierska E., Mycoplasma pneumoniae -induced pneumonia with Stevens-Johnson syndrome of acute atypical course. Polskie Archiwum Medycyny Wewnetrznej 2008 118 7-8 449 453 2-s2.0-49249125368
5. Tsai V., Oman J., Stevens-Johnson syndrome after Mycoplasma pneumoniae infection. The Journal of Emergency Medicine 2011 40 3 324 327 2-s2.0-79952817346 10.1016/j.jemermed.2008.02.027
6. Cherry J. D., Anemia and mucocutaneous lesions due to Mycoplasma pneumoniae infections. Clinical Infectious Diseases 1993 17 supplement 1 S47 S51 2-s2.0-0027321443 (Pubitemid 23227105)
7. Hammerschlag M. R., Mycoplasma pneumoniae infections. Current Opinion in Infectious Diseases 2001 14 2 181 186 2-s2.0-0035082407 (Pubitemid 32231104)
8. Martínez M. A., Ruiz M., Zunino E., Luchsinger V., Avendaño L. F., Detection of Mycoplasma pneumoniae in adult community-acquired pneumonia by PCR and serology. Journal of Medical Microbiology 2008 57 12 1491 1495 2-s2.0-57749174870 10.1099/jmm.0.2008/003814-0
9. Schneck J., Fagot J. P., Sekula P., Sassolas B., Roujeau J. C., Mockenhaupt M., Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective study on patients included in the prospective EuroSCAR Study. Journal of the American Academy of Dermatology 2008 58 1 33 40 2-s2.0-37349096285 10.1016/j.jaad.2007.08.039 (Pubitemid 350298143)
10. Metry D. W., Jung P., Levy M. L., Use of intravenous immunoglobulin in children with Stevens-Johnson syndrome and toxic epidermal necrolysis: seven cases and review of the literature. Pediatrics 2003 112 6 1430 1436 2-s2.0-0346850814 10.1542/peds.112.6.1430 (Pubitemid 37523435)
11. Bachot N., Revuz J., Roujeau J. C., Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no benefit on mortality or progression. Archives of Dermatology 2003 139 1 33 36 2-s2.0-0037233824 10.1001/archderm.139.1.33 (Pubitemid 36091571)